BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
David E. Kaplan, Kyong-Mi Chang. Current status of vaccine therapy for hepatitis c infectionCurrent Hepatitis Reports 2006; 5(2): 68 doi: 10.1007/s11901-006-0007-y
2
Peng Peng Ip, Hans W. Nijman, Jan Wilschut, Toos Daemen. Therapeutic vaccination against chronic hepatitis C virus infectionAntiviral Research 2012; 96(1): 36 doi: 10.1016/j.antiviral.2012.07.006
3
Ke-Yi Liu, Dian-Bo Zhang, Qing-Kuan Wei, Jin Li, Gui-Ping Li, Jin-Zhi Yu. Biological role of surface Toxoplasma gondii antigen in development of vaccineWorld Journal of Gastroenterology 2006; 12(15): 2363-2368 doi: 10.3748/wjg.v12.i15.2363
4
Jin-Won Youn, Yu-Wen Hu, Nancy Tricoche, Wolfram Pfahler, Mohamed Tarek Shata, Marlene Dreux, François-Loic Cosset, Antonella Folgori, Dong-Hun Lee, Betsy Brotman, Alfred M. Prince. Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia VirusJournal of Virology 2008; 82(21): 10896 doi: 10.1128/JVI.01179-08
5
Marcelo Hill, Ala-Eddine Deghmane, Mercedes Segovia, Maria Leticia Zarantonelli, Gaëlle Tilly, Philippe Blancou, Gaëlle Bériou, Régis Josien, Ignacio Anegon, Eva Hong, Corinne Ruckly, Aude Antignac, Meriem El Ghachi, Ivo Gomperts Boneca, Muhamed-Kheir Taha, Maria Cristina Cuturi, Javed N. Agrewala. Penicillin Binding Proteins as Danger Signals: Meningococcal Penicillin Binding Protein 2 Activates Dendritic Cells through Toll-Like Receptor 4PLoS ONE 2011; 6(10): e23995 doi: 10.1371/journal.pone.0023995
6
Wing-pui Kong, Ling Xu, Konrad Stadler, Jeffrey B. Ulmer, Sergio Abrignani, Rino Rappuoli, Gary J. Nabel. Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus ImmunizationJournal of Virology 2005; 79(22): 13915 doi: 10.1128/JVI.79.22.13915-13923.2005
7
Jia-Yu Chen, Fan Li. Development of hepatitis C virus vaccine using hepatitis B core antigen as immuno-carrierWorld Journal of Gastroenterology 2006; 12(48): 7774-7778 doi: 10.3748/wjg.v12.i48.7774
8
M. Ghorbani, T. Nass, A. Azizi, C. Soare, S. Aucoin, A. Giulivi, D.E. Anderson, F. Diaz-Mitoma. Comparison of Antibody- and Cell-Mediated Immune Responses After Intramuscular Hepatitis C Immunizations of BALB/c MiceViral Immunology 2005; 18(4): 637 doi: 10.1089/vim.2005.18.637
9
Jarrod Bailey. An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 1. Validity of the Chimpanzee ModelAlternatives to Laboratory Animals 2010; 38(5): 387 doi: 10.1177/026119291003800501
10
Makutiro Ghislain Masavuli, Danushka K. Wijesundara, Alexander Underwood, Dale Christiansen, Linda Earnest-Silveira, Rowena Bull, Joseph Torresi, Eric J. Gowans, Branka Grubor-Bauk. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated MiceFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01145
11
Yi-Ping Li, Hye Na Kang, Lorne A Babiuk, Qiang Liu. Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal modelsWorld Journal of Gastroenterology 2006; 12(44): 7126-7135 doi: 10.3748/wjg.v12.i44.7126